U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07795645) titled 'Validating a Medical AI Fine-Tuning Platform for Major Diseases' on Aug. 26.
Brief Summary: The goal of this observational study is to leverage the abundant patient resources and standardized medical records from Beijing Friendship Hospital, Xuanwu Hospital, and Beijing Anzhen Hospital, combined with the existing data and knowledge platform of guidelines, consensus, medical literature, and dialogue data from Beijing Haitian Ruisheng Science Technology Co.,Ltd, with Beijing Zhilan Medical Technology Co., Ltd. conducting the fine-tuning, optimization, and validation of the medical large language model. The model is fine-tuned accordin...